MAKO MEDICAL ADDS COST-EFFECTIVE, MASS SCREENING ANTIGEN TEST

By Globe Newswire1 day ago

Raleigh, North Carolina, Feb. 23, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, is offering a new, cost-effective mass screening antigen test to help fight the pandemic. The new MAKO Antigen test utilizes the DiaSorin LIAISONĀ® SARS-CoV-2 Ag high-throughput antigen test for COVID-19, which allows for an additional option to detect the virus in people suspected of having COVID-19 by their healthcare provider.

"Our MAKO team is excited to partner with Diasorin to bring this highly sensitive antigen test to the masses," said Josh Arant, COO, MAKO Medical. "With a sensitivity of 97.1% and a specificity of 100%, utilizing nasal and nasopharyngeal swabs, MAKO can turn results around in less than 24 hours with a capacity to run over 100,000 tests per day."

The MAKO Antigen test allows for the identification of SARS-CoV-2 N protein antigen, which is generally detectable during the acute phase of infection. The test combines a highly accurate in-lab antigen test with a platform capable of supporting large-scale screening of the active virus ...

Full story available on Benzinga.com

Continue read on benzinga.com